4//SEC Filing
DelMar Pharmaceuticals, Inc. 4
Accession 0001213900-17-006196
$HURACIK 0001498382operating
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 5:12 PM ET
Size
4.5 KB
Accession
0001213900-17-006196
Insider Transaction Report
Form 4
BACHA JEFFREY
CEO and President10% Owner
Transactions
- Purchase
Common Stock
2017-06-06$2.12/sh+5,000$10,600→ 46,645 total
Documents
Issuer
DelMar Pharmaceuticals, Inc.
CIK 0001498382
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001498382
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 5:12 PM ET
- Size
- 4.5 KB